ZVSA · ZyVersa Therapeutics, Inc. · Investor Relations
$0.19
-0.13 (-40.51%)
At close · Jul 17
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about our ability to continue as a going concern for 12 months after the issuance date of our financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$833,880
Shares
8.10M
Volume · Jul 17
1.71M
Avg daily vol (3M)
5.63M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-06-11 | Replay ZyVersa Virtual Shareholder Meeting 2025 | Shareholder meeting |
| 2025-03-04 | Special Meeting of Stockholders (Virtual) | Shareholder meeting |
| 2024-11-14 | CEO Chat: Life Sciences Investor Forum | Event |
| 2024-10-29 | Shareholder Meeting 2024 (Virtual) | Shareholder meeting |
| 2024-10-15 | The Big Biz Show Interview on Obesity Market | Event |
| 2024-04-17 | Special Meeting of Stockholders (Virtual) | Shareholder meeting |
| 2024-03-20 | Benzinga Health Care Summit 2024 | Event |
| 2024-01-11 | The Big Biz Show Interview | Event |
| 2024-01-04 | The Big Biz Show Interview | Event |